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| INTRODUC TI ON
Orthotopic liver transplantation is the only effective therapy in patients with end-stage liver disease. Still, donor availability is the main limiting factor in liver transplantation, especially in pediatric patients, who need a perfect size-appropriate graft. 1 To expand the number of suitable liver grafts for pediatric recipients, several technical variants are practiced, including splitting of deceased adult donor liver grafts and the use of living donors. Despite this, waiting list mortality rate is up to 20%. 2 Moreover, during the period on the waiting list children are at great risk of growth and developmental retardation.
For adults, DCD liver grafts are increasingly used to expand the donor pool. Good results with transplantation of DCD liver grafts are reported, but a major concern remains the high rate of biliary complications. For children, the use of DCD grafts is still controversial and the available data are limited to small series. 3, 4 To improve outcome of DCD liver transplantation, ex situ HMP is increasingly used as an alternative strategy for organ preservation, with the supplemental value of providing oxygen to the graft during preservation. 5 The initial experience in adults has demonstrated that end-ischemic HMP provides better preservation of DCD liver grafts.
HMP ameliorates ischemia-reperfusion injury in DCD liver grafts by restoring mitochondrial function before implantation, and it offers better preservation of the bile ducts and their vasculature. 6, 7 This is an important step forward in reducing biliary complications after DCD liver transplantation.
So far, machine perfusion has only been reported in adult to adult liver transplantation. We here report the first successful transplantation of a pediatric DCD liver graft after oxygenated HMP.
| Case Presentation
The liver graft was derived from a 13-year-old, female DCD donor (65 kg, 167 cm), who was resuscitated after an out of hospital cardiac arrest. She was admitted to the intensive care unit for 7 days.
Last serum ALT before procurement was 65 U/L, and last serum sodium was 162 mmol/L. The agonal phase between withdrawal from life support until circulatory arrest was 19 minutes. After a mandatory 5 minutes "no touch period," rapid cannulation of the aorta was performed and the liver was in situ perfused with ice-cold Belzer UW cold storage solution (supplemented with heparin). The total period from withdrawal of life support to in situ cold perfusion endured 34 minutes. The bile ducts were gently flushed in a retrograde fashion with UW preservation solution. Subsequently, the liver was packed static cold storage and transported to our center.
In our center, the liver graft was inspected and appeared to be of good quality. Liver weight was 1509 g. Because the liver was derived from a DCD donor and to minimize further ischemic injury as much as possible, it was decided to prepare the liver graft for oxygenated HMP during recipient hepatectomy. A conventional back table procedure of the graft was performed after which the portal vein and supratruncal aorta were cannulated for machine perfusion.
Subsequently, the liver underwent pressure-controlled dual hypothermic oxygenated machine perfusion using the Liver Assist (Organ Assist, Groningen, The Netherlands). The perfusion fluid consisted of 4000 mL Belzer UW machine perfusion solution, supplemented with 3420 mg glutathione. Perfusion fluid was oxygenated with 1 L/ min 100% O2 to obtain a PaO2 of >70 mm Hg, and temperature was kept at 10°C, according to our HMP protocol. 6 Arterial and portal pressures were set at 18 and 4 mm Hg, respectively, which is slightly lower than our protocolized settings for adult livers (25 and 5 mm Hg, respectively). During HMP, portal flow increased adequately from 100 to 210 mL/min and arterial flow from 30 to 63 mL/min, whereas pressure and temperature remained stable ( Figure 1 ). Perfusate glucose level increased in the first 30 minutes of HMP from 8.8 to 12.5 mmol/L and remained stable thereafter. The perfusate lactate level decreased from 2.4 to 1.7 mmol/L. After 2 hours of HMP, the liver was disconnected from the perfusion machine and transplanted.
The selected recipient was a 16-year-old girl (42 kg, 156 cm), who was diagnosed in the neonatal phase with progressive familial intrahepatic cholestasis type 2. To prevent progressive damage of the hepatocytes by retention and accumulation of bile salts, a partial external biliary diversion procedure was performed when she was 4 years old. 8 Despite this, at the age of 14 years she was listed for liver transplantation because of deterioration of cholestasis with icterus and itching, and bile stoma bleedings. The recipient and her parents gave consent to receive a HMP-preserved DCD liver.
The HMP-pretreated full-size liver graft was implanted using the piggyback technique with end-to-end portal and arterial anastomoses.
Perioperative blood loss was 1800 mL, and the recipient received one red blood cell transfusion (280 mL) intraoperatively. Total cold preservation time of the donor liver graft was 512 minutes, consisting of 384 minutes of cold ischemic storage and 128 minutes of oxygenated HMP. Subsequent warm ischemia time was 33 minutes. Immediately F I G U R E 1 Portal and arterial flow rates during two hours of dual hypothermic oxygenated machine perfusion of a 13-year-old DCD liver graft. The perfusion machine was pressure-controlled with portal pressure set at 4 mm Hg and arterial pressure set at 18 mm Hg. DCD, donation after circulatory death after transplantation, the recipient was extubated and admitted to the pediatric intensive care unit where vasopressive support could be reduced to zero and intravenous heparin was administered as is routine practice after pediatric transplantation in our center. Postoperative AST, ALT, and prothrombin time rapidly decreased and normalized within a week (Figure 2A ). ALP and GGT normalized within a month and remained stable afterward. Immediate postoperative lactate was 3.5 mmol/L and levels steadily decreased thereafter, with a small second peak on postoperative day four when an intra-abdominal bleeding was diagnosed, which required surgical intervention ( Figure 2B ).
Surgical inspection showed diffuse oozing with a potential bleeding focus at the inferior vena cava, which was clipped, and additionally, a hematoma was evacuated. After this, the recipient had a quick and further uneventful recovery until she was discharged from the hospital on postoperative day 18. One year later, the recipient is in excellent condition with a completely normal liver function with a serum ALT of 16 U/L, bilirubin of 7 µmol/L, and a normal liver histology on routine liver biopsy. There were no clinical or histological signs of biliary complications, and additional imaging was not performed. These studies support the use of pediatric DCD liver grafts for transplantation.
| D ISCUSS I ON
A major drawback of DCD liver grafts is the devastating effect of warm with subsequent cold ischemia, leading to depletion of intracellular energy sources, such as adenosine 5'-triphosphate, combined with other metabolic disturbances. This results into cellular injury and dysfunction due to reperfusion injury during transplantation. 10, 11 Ischemia-reperfusion injury is a major cause of primary non-function, early allograft dysfunction, and biliary complications after transplantation. 12 In adult liver transplantation, it has been demonstrated that a short period (1-2 hours) of oxygenated HMP after traditional static cold storage restores the hepatic energy status in liver grafts, reduces ischemia-reperfusion injury and improves early graft survival. 5, 6, 13 Based on these experiences, we decided to apply end-ischemic HMP to the pediatric DCD liver graft offered to our recipient. Compared to adult liver grafts, pediatric livers are smaller and potentially more susceptible to intravascular pressure-induced damage. This is important because one of the potential risks of HMP is endothelial injury due to shear stress. Shear stress occurs in case of high perfusion pressures, especially at low temperatures when endothelial cell membranes are susceptible to injury. 14 Perfusion-induced endothelial cell injury can be prevented by using low perfusion pressures and a pressure-controlled perfusion system. 13, 15 Therefore, we used a pressure-controlled machine perfusion device with arterial and portal perfusion pressures lower than values generally used for adult liver grafts. 16 In the reported case, we demonstrated HMP of a 13-year-old DCD liver graft, which was relatively large. To determine optimal portal and arterial pressures for HMP in pediatric liver grafts, more experiences and research are required. In our opinion, perfusion pressures in pediatric liver grafts should be lowered based on donor age, to adjust for the lower physiological pressure in the liver graft. For HMP in adult liver grafts, protocolized portal and arterial perfusion pressures are set at 3-5 and 25 mm Hg, respectively. 6, 13 Normally, an adult liver graft is used to a physiological mean arterial blood pressure of 90 mm Hg in the donor, whereas pediatric liver grafts are used to lower systemic blood pressures. Perhaps we should lower perfusion pressures for pediatric liver grafts based on donor mean arterial blood pressures according to donor age. For example, a 5-year-old pediatric liver graft is used to a mean arterial blood pressure of 65 mm Hg, which is about 30% lower when compared to 90 mm Hg in adults. Therefore, it seems reasonable to reduce the portal and arterial pressure with 30%, lead- Apart from providing a better preservation method, machine perfusion can also facilitate pediatric liver transplantation by enabling a split procedure of a liver graft under continuous oxygenated perfusion. The concept of splitting a liver graft during machine perfusion was recently shown by Stephenson et al. 17 These investigators successfully performed a split procedure of an adult liver graft resulting in a segment 2/3 and an extended right lobe graft. In addition, with the upcoming technique of normothermic machine perfusion, which enables ex situ functional assessment of the liver graft prior to implantation, it might be useful to estimate the suitability of a suboptimal liver graft for a pediatric recipient. 18 Altogether, this may increase the number of liver grafts that are suitable for pediatric liver transplantation.
In conclusion, we present the first successful transplantation of a pediatric DCD liver graft after ex situ hypothermic oxygenated machine perfusion. This case illustrates the potential role of ex situ machine perfusion technology in expanding the donor pool and improving outcome after pediatric liver transplantation.
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